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Abstract
Background: Stable angina pectoris is a serious condition with few epidemiological studies in Brazil.
Objective: To validate the short-version of the Rose angina questionnaire in Brazilian Portuguese for its implementation 
in surveys and longitudinal studies.
Methods: A total of 116 consecutive patients from an outpatient clinic without prior myocardial infarction and/or 
coronary revascularization were enrolled for application of three questions of the Rose angina questionnaire addressing 
chest pain after exertion. We used the treadmill test as the gold standard with the Ellestad protocol.
Results: The short-version of the Rose angina questionnaire of the 116 subjects submitted to the exercise treadmill 
test disclosed 89.7% of accuracy, 25% of sensitivity, 92.0% of specificity, 10.0% of positive predictive value, 97.2% of 
negative predictive value, and 3.1 of positive likelihood ratio and 0.82 of negative likelihood ratio.
Conclusion: The Portuguese version with three items of the Rose angina questionnaire is suitable for epidemiological 
purposes. (Arq Bras Cardiol 2012;99(5):1056-1059)
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Introduction
The estimation of prevalence and incidence of angina 
pectoris has been a challenge for cardiovascular epidemiology. 
Epidemiological studies addressing temporal trends and 
international comparison of mortality death rates are a relevant 
and low-cost tool for estimation of the burden of Coronary 
Heart Disease (CHD), such as sudden death and myocardial 
infarction1. However, these descriptions of death rates do not 
permit to measure one pivotal point of the broad spectrum 
of CHD: stable angina pectoris.  Nowadays, there are some 
instruments to quantify angina pectoris as primary-care medical 
records; frequency of prescription of nitrates; self-report of 
current or ever-experienced angina, and the “Rose Angina 
Questionnaire”2. In 1962, Geoffrey A. Rose (*1926-†1993), 
a British physician and professor of epidemiology developed 
a new tool for surveys and epidemiological studies -but not 
for clinical use-: one test with seven questions including the 
diagram of a male thorax. It allowed estimating the prevalence 
of stable angina pectoris. For validation, he compared the 
answers from volunteers with a clinical evaluation of two 
senior cardiologists as the gold standard (reference test). 
Later, this questionnaire was recommended by the World 
Health Organization (WHO) as a general instrument for the 
determination of angina prevalence, and since then it has been 
known as “WHO-Rose Angina Questionnaire”3.
Until the year 2005, the application of the Rose 
questionnaire was identified in 74 studies of 13,331 angina 
cases in women and 11,511 cases in men from 31 countries. 
Angina prevalence varied widely across these different settings 
from 0.73% to 14.4% in women and from 0.76% to 15.1% 
in men4. In Brazil, the full version of the Rose questionnaire 
was applied in Pelotas, Rio Grande do Sul  to 1680 individuals 
older than 40 years  showing a prevalence of angina of 8.2%5. 
In 2003, Lawlor et al.6 proposed a short-version of the 
WHO-Rose angina questionnaire that focused on only 
three questions dealing with chest pain after exertion. They 
compared the two questionnaires in women using as the gold 
standard data from a primary care consultation for angina 
symptoms within the past five years. The short-questionnaire 
was more sensitive (from 33% to 51.8%) and slightly less 
specific (from 93.8% to 89.4%) than the original version of 
the Rose questionnaire. They concluded that applying the 
three-item Rose angina questionnaire can be suitable for 
epidemiological studies6. More recently, the SMART study in 
Netherlands, a 4.6-year follow-up of 7,916 consecutive patients 
with clinically diagnosed disease or cardiovascular risk 
factors, compared the standard Rose questionnaire and its 
short-version. Discriminatory ability of both approaches 
for coronary events was assessed with areas under the 
receiver-operator characteristics (ROC) curves with similar 
range (0.708-0.726)7. During a 23-year evaluation, in 
a cohort of 30,000 middle-aged apparently healthy 
Norwegians, the three-item Rose questionnaire  identified 
unknown CHD at baseline with hazard ratios to predict acute 
coronary syndrome that were  similar to increase in total 
cholesterol and systolic blood pressure levels8.
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the short form of the WHO Rose angina questionnaire were 
calculated using the exercise treadmill test as the gold standard 
for angina pectoris in a 2x2 table.
The study was approved by the Institutional Boarding 
Committee, and all participants agreed to participate and 
signed the informed consent.
Results
Among the 126 subjects with a mean age of 53.6 (standard 
deviation ±7.0) years submitted to treadmill test, 116 (92.1%) 
presented a conclusive test. Men were 57% of the sample. 
One third of the sample had a 10-year risk of CHD higher 
than 10% by the Framingham Score Risk. Mean time between 
angina questionnaire and exercise treadmill test was 42.2 
(standard deviation ±38.8) days. Ten people (8.6%) answered 
the questionnaire positively for the presence of angina, and 
four subjects (3.4%) had ischemia detected at the treadmill 
test. Table 1 shows that the angina questionnaire of the 116 
subjects submitted to exercise treadmill test disclosing 89.7% 
of accuracy (95% CI, 84.2% - 95.2%), 25% of sensitivity (95% 
CI, 17.2%-32.8%), 92.0% of specificity (95% CI, 88.1%-
95,.9%), 10.0% of positive predictive value , 97.2% (95% CI, 
94.2% - 100%) of negative predictive value (95% CI, 96.9% 
- 97.5%), 3.1 of positive likelihood ratio (95% CI, 2.1 - 16.6) 
and 0.82 of negative likelihood ratio (95% CI, 0.75 – 4.43).
Discussion
This study evaluated the validity of “WHO Rose angina 
questionnaire” for the diagnosis of coronary heart disease 
for individuals without clinically apparent cardiovascular 
disease. Our findings, the sensitivity of 25% and specificity 
of 92% is very similar to previous data reported by Lawlor 
et al. with a female population6. There were differences 
between these two studies related to sampling and reference 
test. Our sample is younger, and it consisted of individuals of 
both genders. We used the treadmill test as reference and they 
considered the medical records within the last five-years as the 
gold standard. However, in this validation, WHO Rose angina 
questionnaire showed high specificity and low sensitivity, as 
expected for a questionnaire used in epidemiologic research. 
Every time a questionnaire is applied to a large sample, 
the objective is to decrease costs and safety concerns. It 
is impracticable to refer thousands of participants to cardiologist 
The aim of this study is to validate of the Portuguese short-
version of “WHO Rose angina questionnaire” in a sample 
using the exercise treadmill test as the gold standard for 
future application in surveys and cohort studies as in the ongoing 
Brazilian Longitudinal Study of Adult Health (ELSA-Brazil)9.
Methods
A total of 126 consecutive patients from an outpatient clinic 
in the city of Sao Paulo, aged 40-74 years with an indication 
for a treadmill test were invited to participate in the study. 
Exclusion criteria were self-report of ever-experienced angina, 
hospitalization due to acute coronary syndrome and refusal to 
participate. As the researchers did not interfere in the selection of 
subjects treated at an academic community-based hospital, we 
expected a good external validity of the results. The sample 
included patients with different probabilities of having angina; the 
number of participants was calculated considering an expected 
sensitivity of 30%, a total width of 0.30 and a 95% confidence 
interval; number of participants of the sample was calculated 
considering an expected sensitivity of 30%, a total width of 0.30 
and a 95% confidence interval; considering these parameters, a 
sample size of 72 patients was estimated10.
The short version of “WHO Rose Angina Questionnaire” was 
applied with the first three questions of the original version4 
translated and adapted to Brazilian Portuguese for use in the 
Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)9. 
Angina was positive when the answer was positive for the 
question: “Do you ever have any pain or discomfort in your 
chest?” and when the answer was affirmative for one of the 
following questions: “Do you get it when you walk at an 
ordinary pace on the level?” or “Do you get it when you walk 
up hill or hurry?”
All participants were submitted to an exercise treadmill 
testing performed with the use of the Ellestad protocol10. The 
test was considered as acceptable if the subject achieved 
85% of the age-predicted maximum heart rate and it was 
positive for ischemia when there was horizontal ST segment 
depression, measured on Y point, ≥1.0mm in men e 1.5 mm 
in women, or descendent, measured on J point, ≥1.0mm in 
men and 1.5 mm in women, or slow ascending, measured 
at the Y point, ≥ 1.5 mm in men e ≥ 2.0 mm in women.
Sensitivity, specificity, positive and negative predictive 
values, positive and negative likelihood ratios and accuracy of 
Table 1 - Sensitivity, specificity, accuracy, positive and negative predictive value, positive and negative likelihood ratio of angina 
questionnaire by ischemia during exercise treadmill testing in 116 subjects
Exercise Treadmill Testing
Positive Negative Total
Rose Questionnaire
Positive 1 9 10
Negative 3 103 106
total 4 112 116
Note: sensitivity 25.0% (95% CI, 17.2%-32.8%), specificity 92.0% (95% CI, 88.1%-95.9%), accuracy 89.7% (95% CI, 84.2% - 95.2%), positive predictive value 10.0% 
(95% CI, 94.2% - 100%) negative predictive value 97.2% (95% CI, 96.9% - 97.5%), positive likelihood ratio 3.3 (95% CI, 2.1 - 16.6), negative likelihood ratio 0.82 
(95% CI, 0.75 – 4.43). 
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assessment and scintigraphy. Based on this assumption, the 
prevalence of disease in the population sampled and the 
gold standard used are the critical points for evaluation of a 
questionnaire for epidemiological purposes. It is appropriate to 
emphasize that both physicians and epidemiologists need 
an accurate disease definition; however they are addressing 
different goals with individuals, and population, respectively. 
Physicians work with a great variety of symptoms for the 
same disease, and they use broad definitions of diseases 
that try to cover all clinical presentations. Epidemiologists 
use a more restricted definition of diseases, as they want 
to compare their results with data obtained in different 
places and periods. Thus, physicians try to work with highly 
sensitive definitions of disease and epidemiologists try to 
work with more specific definitions. This explains why 
questionnaires used in epidemiological studies often have 
high specificity and low sensitivity2. We chose a relatively 
homogenous population that consisted of patients who had not 
had confirmed CHD - previous myocardial infarction and/or 
coronary revascularization -  and apparently healthy volunteers.
Our study was the first in Brazil that used the short version of 
Rose angina questionnaire, the same that has been applied in 
the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)9. 
It can be used to evaluate prevalence in surveys and for 
incidence of angina in longitudinal studies2. 
Conclusion
A sho r t - ve r s ion  o f  the  “ WHO -Rose  Ang ina 
Questionnaire” with three questions about chest pain after 
exertion can be applied in epidemiological studies.
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